Nature Communications (Aug 2020)

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

  • Liqiang Feng,
  • Qian Wang,
  • Chao Shan,
  • Chenchen Yang,
  • Ying Feng,
  • Jia Wu,
  • Xiaolin Liu,
  • Yiwu Zhou,
  • Rendi Jiang,
  • Peiyu Hu,
  • Xinglong Liu,
  • Fan Zhang,
  • Pingchao Li,
  • Xuefeng Niu,
  • Yichu Liu,
  • Xuehua Zheng,
  • Jia Luo,
  • Jing Sun,
  • Yingying Gu,
  • Bo Liu,
  • Yongcun Xu,
  • Chufang Li,
  • Weiqi Pan,
  • Jincun Zhao,
  • Changwen Ke,
  • Xinwen Chen,
  • Tao Xu,
  • Nanshan Zhong,
  • Suhua Guan,
  • Zhiming Yuan,
  • Ling Chen

DOI
https://doi.org/10.1038/s41467-020-18077-5
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 11

Abstract

Read online

A vaccine protecting from SARS-CoV-2 infection is needed. Here the authors generate a replication-incompetent adenovirus based vaccine expressing SARS-CoV-2 spike, show protection from infection in non-human primates, and analyze the immune response after intramuscular and intranasal vaccination.